AJUBA通过磷酸化STAT5促进间充质干细胞向成骨分化命运决定的机制研究
结题报告
批准号:
31970679
项目类别:
面上项目
资助金额:
52.0 万元
负责人:
贾浩
依托单位:
学科分类:
细胞命运及重编程
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
贾浩
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
间充质干细胞(mesenchymal stem cells,MSCs)是一类具有自我更新和分化潜能的成体干细胞。利用MSCs分化为成骨细胞治疗骨质疏松是目前研究的热点和难点。我们前期发现 AJUBA被Smad1调控,AJUBA敲除小鼠骨量丢失,向成骨细胞分化能力减弱,RNA-seq发现STAT5和Runx2的表达下调,STAT5的磷酸化被抑制。我们提出科学假说:AJUBA通过激活STAT5的磷酸化及入核,上调Runx2等下游基因的表达,促进MSCs向成骨细胞分化。本课题将研究:1、明确AJUBA激活STAT5/Runx2信号通路促进MSC向成骨细胞分化的命运决定;2、阐明AJUBA在MSCs被BMP-Smad1调控的分子机制;3、探讨AJUBA作为诱导MSCs分化成骨细胞治疗骨质疏松的可行性。对以上问题的回答,期望完善MSCs分化成骨细胞的分子机制,为骨质疏松的预防和治疗提供可能性与策略。
英文摘要
Mesenchymal stem cells (MSCs) are a class of adult stem cells with self-renewal and differentiation potential. The use of MSCs to differentiate into osteoblasts for the treatment of osteoporosis is a hot and difficult point in current research. Previously, AJUBA was regulated by Smad1, AJUBA knockout mice were found to lose bone mass and weaken their ability to differentiate into osteoblasts. RNA-Seq was found to down-regulate the expression of STAT5 and Runx2, and phosphorylation of STAT5 was inhibited. Based on the above research, a scientific hypothesis was proposed: AJUBA activates STAT5 Phosphorylation and nuclear import, up-regulation of Runx2 and other downstream gene expression, and promotion of MSC differentiation into osteoblasts. In this project: 1. We would identify AJUBA's activation of STAT5/Runx2 signaling pathway to promote the fate of MSC to osteoblast differentiation; 2. We would elucidate the molecular mechanism of AJUBA in the regulation of MSCs by BMP-Smad1; 3. We would explore the feasibility of AJUBA as an induced MSC differentiation into osteoblasts for the treatment of osteoporosis, the answer to the above questions, it is expected that the perfect MSC differentiation into osteoblasts. The molecular mechanism provides possibilities and strategies for the prevention and treatment of osteoporosis.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.3969/j.issn.1000-484x.2023.07.033
发表时间:2023
期刊:中国免疫学杂志
影响因子:--
作者:陈晓琳;杨于权;侯照远;贾浩
通讯作者:贾浩
DOI:10.1016/j.heliyon.2023.e23318
发表时间:2024-01-15
期刊:HELIYON
影响因子:4
作者:Xia, Kexin;Chen, Xiaolin;Wang, Wenyan;Liu, Qianwen;Zhao, Mai;Ma, Jiacheng;Jia, Hao
通讯作者:Jia, Hao
DOI:--
发表时间:2022
期刊:上海交通大学学报 医学版
影响因子:--
作者:江淦;杨于权;陈曜星;侯照远;高小玲;陈红专;贾浩
通讯作者:贾浩
DOI:10.1016/j.mce.2021.111485
发表时间:2021-10
期刊:Molecular and Cellular Endocrinology
影响因子:4.1
作者:Han Yan;Qi Li;Mengying Li;X. Zou;N. Bai;Zichao Yu;Jie Zhang;Dan Zhang;Qun Zhang;Jiamin Wang;Hao Jia;Yingjie Wu;Z. Hou
通讯作者:Han Yan;Qi Li;Mengying Li;X. Zou;N. Bai;Zichao Yu;Jie Zhang;Dan Zhang;Qun Zhang;Jiamin Wang;Hao Jia;Yingjie Wu;Z. Hou
DOI:--
发表时间:2020
期刊:上海交通大学学报 (医学版)
影响因子:--
作者:崔雅琦;白玉冰;许怡晨;谭心辰;李梦莹;贾浩
通讯作者:贾浩
AJUBA调控IFIT2介导的细胞凋亡及其在结直肠癌发展中的作用与机制研究
  • 批准号:
    31601114
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    贾浩
  • 依托单位:
国内基金
海外基金